Education
About Us
Working with TipRanks
Follow Us
Opyl Ltd. (AU:OPL)
ASX:OPL
OPL Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.03
Previous CloseN/A
Volume499.54K
Average Volume (3M)352.81K
Market Cap
AU$4.46M
Enterprise ValueAU$1.73M
Total Cash (Recent Filing)AU$329.55K
Total Debt (Recent Filing)AU$428.41K
Price to Earnings (P/E)―
Beta0.56
Next Earnings
Aug 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding234,968,320
10 Day Avg. Volume370,446
30 Day Avg. Volume352,807
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)-4.03
Price to Sales (P/S)0.00
P/FCF Ratio-0.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Opyl Ltd. News
PremiumCompany Announcements
Opyl Partners with Innovatrix to Launch Clinical Trial Insurance
PremiumCompany Announcements
Opyl Limited Issues 42 Million Shares, Strengthening Market Position
PremiumCompany Announcements
Opyl Ltd. Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Opyl Limited Announces Proposed Securities Issue
PremiumCompany Announcements
Opyl Ltd. Announces Proposed Issue of 8 Million Unlisted OptionsPremiumCompany Announcements
Opyl Limited Secures $1.5 Million to Boost AI Drug Discovery PlatformOptions Prices
Currently, No data available
---
Ownership Overview
28.81% Insiders
―
Mutual Funds
― Other Institutional Investors
71.19% Public Companies and
Individual Investors
OPL FAQ
What was Opyl Ltd.’s price range in the past 12 months?
Opyl Ltd. lowest share price was AU$0.01 and its highest was AU$0.03 in the past 12 months.
What is Opyl Ltd.’s market cap?
Opyl Ltd.’s market cap is AU$4.46M.
When is Opyl Ltd.’s upcoming earnings report date?
Opyl Ltd.’s upcoming earnings report date is Aug 27, 2025 which is in 69 days.
How were Opyl Ltd.’s earnings last quarter?
Opyl Ltd. released its earnings results on Feb 27, 2025. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.004.
Is Opyl Ltd. overvalued?
According to Wall Street analysts Opyl Ltd.’s price is currently Overvalued.
Does Opyl Ltd. pay dividends?
Opyl Ltd. does not currently pay dividends.
What is Opyl Ltd.’s EPS estimate?
Opyl Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Opyl Ltd. have?
Opyl Ltd. has 234,968,320 shares outstanding.
What happened to Opyl Ltd.’s price movement after its last earnings report?
Opyl Ltd. reported an EPS of -AU$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Opyl Ltd.?
Currently, no hedge funds are holding shares in AU:OPL
Opyl Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:OPL Sentiment 100%
Sector Average 67%
Sector Average 67%
Insider Transactions
Bought Shares
Worth AU$116.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.66%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-41.63%
Trailing 12-Months
Company Description
Opyl Ltd.
Opyl Limited develops digital tools that enhance healthcare experience for patients in Australia. The company also delivers deep market insights from social media data and enhance clinical research process. It offers Opin, a clinical trial recruitment platform that leverages social media, search engine optimization technologies and emerging artificial intelligence science, and matching patients directly to clinical trials; and social media marketing agency services, such as client and account management services for pharmaceutical, medtech, and biotech industries. The company was formerly known as ShareRoot Limited and changed its name to Opyl Limited in December 2019. Opyl Limited was incorporated in 1994 and is based in St Kilda, Australia.
Technical Analysis
Imugene Limited
―
PYC Therapeutics Limited
―
Race Oncology Ltd.
―
Cryosite Limited
―
Australian Clinical Labs Ltd
―